CYTODYN INC (CYDY:OTCMKTS)
$0.285 -0.005 (-1.7241%)
Analysed CYTODYN INC (CYDY:OTCMKTS) News Sources
CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer
24-03-2026
yahoo.com
CytoDyn to Present at the AACR Annual Meeting 2026
14-04-2026
yahoo.com
CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026
20-04-2026
yahoo.com
CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study
21-04-2026
yahoo.com
CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026
22-04-2026
yahoo.com
CytoDyn to Host Investor Webcast
23-04-2026
yahoo.com
CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer
27-04-2026
yahoo.com
CytoDyn to Present at the LD Micro Invitational XVI
15-05-2026
yahoo.com
Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer
04-06-2026
yahoo.com
CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer’s Disease
11-06-2026
yahoo.com
What is the current price of CYTODYN INC (CYDY:OTCMKTS)?
The current price of CYTODYN INC (CYDY:OTCMKTS) is $0.285.
CYTODYN INC (CYDY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CYTODYN INC (CYDY:OTCMKTS) since the previous trading day is $-0.005.
CYTODYN INC (CYDY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CYTODYN INC (CYDY:OTCMKTS) since the previous trading day is -1.7241%.
What is the most recent average sentiment score for CYTODYN INC (CYDY:OTCMKTS)?
The most recent average sentiment score for CYTODYN INC (CYDY:OTCMKTS) is 79 out of 100.
What is the most recent average sentiment for CYTODYN INC (CYDY:OTCMKTS)?
The most recent sentiment for CYTODYN INC (CYDY:OTCMKTS) is .
SEC-8K** Filing Available For CYTODYN INC (CYDY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.